Skip to content

Cluster randomized trial using 'relay test' to promote PCR self-sampling detection of human papillomavirus (HPV) in China females

Cluster randomized trial using 'relay test' to promote PCR self-sampling detection of human papillomavirus (HPV) in China females

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095770
Enrollment
Unknown
Registered
2025-01-13
Start date
2025-01-20
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HPV infection

Interventions

Prepaid HPV self sampling group:The intervention group employs a prepayment mechanism for HPV self-sampling, requiring participants to pay a fee of 20 RMB as an economic incentive before receiving the
Free distribution of HPV self-sampling group:HPV self-sampling kits were provided to participants free of charge.?After the participants complete self-sampling, they will send the samples back to the
the test results will be fed back to the participants in time by telephone or SMS. For participants with positive HPV test, we will provide free follow-up treatment services including doctor consultat

Sponsors

Inner Mongolia Maternity and Child Health Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
24 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Women aged 24 and above. 2. Having Chinese nationality and residing in Hohhot for at least 6 months. 3. I have not undergone HPV self testing or cervical cancer screening in the past 12 months. 4. I have not received the HPV vaccine in the past. 5. Having a mobile phone number and being able to use a smartphone. 6. Can understand and sign informed consent forms. 7. No serious physical or mental illness, able to complete the entire research process.

Exclusion criteria

Exclusion criteria: 1. Women with a history of cervical cancer or cervical intraepithelial neoplasia. 2. Pregnant women. 3. Women participating in other clinical studies related to HPV.

Design outcomes

Primary

MeasureTime frame
Feedback rate of HPV self-test results;

Secondary

MeasureTime frame
HPV positivity rate;Follow up diagnosis and treatment adherence ;Satisfaction survey;

Countries

China

Contacts

Public ContactXueyuan Zhou

Inner Mongolia Maternity and Child Health Care Hospital

382263699@qq.com+86 150 2490 8305

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026